Pricing Log in Create free account
Saturday 17 October 2026 Export HCA’s income statement to Excel — free account

HCA Healthcare, Inc.

HCA Healthcare Medical Care Facilities

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.

457.58 10.92 −2.33%
Market cap
$101.4B
P/E
15.3×
Fwd P/E
12.3×
Dividend yield
0.67%
F-score
7/9
Altman Z
2.80
Beneish M
−2.87
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

HCA Healthcare, Inc. (HCA) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Jul 29, 2026 2.03 Creation of a direct financial obligation; 8.01 Other events
10-Q Jun 30, 2026 P1I2: 21 added · 7 removed · 33 modified
P2I1A: no comparison — incorporated by reference
8-K Jul 24, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jul 14, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 15, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Apr 27, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 23, 2026 5.07 Submission of matters to a vote of security holders
8-K Apr 27, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Apr 24, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 20, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 18 added · 19 removed · 105 modified
1A: 15 added · 16 removed · 67 modified
7: 8 added · 3 removed · 34 modified
8-K Jan 27, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Oct 27, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 27, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Oct 24, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.